The in ovo electroporation in chicken embryos has widely been used as a powerful tool to study roles of genes during embryogenesis. However, the conventional electroporation technique fails to retain the expression of transgenes for more than several days because transgenes are not integrated into the genome. To overcome this shortcoming, we have developed a transposon-mediated gene transfer, a novel technique in chicken manipulations. It was previously reported that the transposon Tol2, originally found in medaka fish, facilitates an integration of a transgene into the genome when co-acting with Tol2 transposase. In this study, we co-electroporated a plasmid containing a CAGGS-EGFP cassette cloned in the Tol2 construct along with a transposase-encoding plasmid into early presomitic mesoderm or optic vesicles of chicken embryos. This resulted in persistent expression of EGFP at least until embryonic day 8 (E8) and E12 in somite-derived tissues and developing retina, respectively. The integration of the transgene was confirmed by genomic Southern blotting using chicken cultured cells. We further combined this transposon-mediated gene transfer with the tetracycline-dependent conditional expression system that we also developed recently. With this combined method, expression of a stably integrated transgene could be experimentally induced upon tetracycline administration at relatively late stages such as E6, where a variety of organogenesis are underway. Thus, the techniques proposed in this study provide a novel approach to study the mechanisms of late organogenesis, for which chickens are most suitable model animals.
Introduction
The chicken embryo has been a remarkably important model system in developmental biology. Its usefulness has recently been expanded by the in ovo electroporation technique, developed in Nakamura's laboratory (Funahashi et al., 1999; Momose et al., 1999; Yasuda et al., 2000) , which has allowed the molecular analyses of tissue interactions, cell differentiation, and pattern formation in these embryos. However, with the conventional technique of electroporation, the expression of a transgene is transient, lasting for merely two to three days in the embryonic cells, even though the electroporated transgene is driven by a ubiquitous promoter, such as CAGGS (Niwa et al., 1991) . This failure of sustained expression is due to the inability of electroporated plasmids to become integrated into the chromosomes, and thus they are diluted as embryonic cells undergo proliferation. For instance, in an experiment where a developing presomitic mesoderm (PSM) is to be manipulated with transgenes, we need to electroporate the genes into the prospective PSM cells that ingress near the primitive streak of an embryo at stage 8. This technique enables a successful transgenesis in PSM and early somites where expression of the introduced gene remains active until early embryonic day 4 (E4). However, from E5 onward, the expression signal rapidly decreases in intensity, and by E6, the signal vanishes (see also below, Fig. 3 ). In addition, it is practically difficult to electroporate DNA into the somites of E4. Thus, the transient expression of the gene has precluded analyses of effects elicited by a transgene at stages later than E5.
To circumvent these problems, we here describe a novel method in chickens using a transposon-mediated gene transfer technique that enables an electroporated gene to be stably integrated into chicken chromosomes. Transposons are genetic elements that move from one locus in the genome to another, and have been used as powerful tools in model animals and plants. Recently, the Tol2 transposable element, which was originally found in medaka (Koga et al., 1996) , has been reported to be capable of undergoing efficient transposition in a wide variety of vertebrate species including zebrafish, frogs and mice (Kawakami et al., 2000; Kawakami et al., 2004a,b; Kawakami and Noda, 2004) . When a DNA plasmid that contains a transposon construct carrying a gene expression cassette is introduced into vertebrate cells with the transposase activity, the transposon construct is excised from the plasmid, and the cassette is subsequently integrated into the host genome (Kawakami, 2005) , see also Fig.  1A ). In this study we exploited this unique character of the transposon to obtain stable integration of an electroporated gene into cultured chicken cells and also into chicken developing embryos. Indeed, the electroporation of a gene cassette cloned in the Tol2 transposon vector has permitted stable expression of the gene in the chicken cells. We further combined this transposon- Fig. 1 . Transposition of Tol2-flanked DNA by transposase. (A) When a DNA is cloned in a Tol2 construct of a plasmid, the Tol2-flanked cassette is excised from the plasmid, and is transposed and integrated into a host genome by a transposase activity. (B) Transfection into DF1 chicken cultured cells with Tol2-flanked CAGGS-EGFP (pT2K-CAGGS-EGFP) and CAGGS-transposase (pCAGGS-T2TP). Until three days after the transfection, a relative ratio of EGFP-positive cells in culture was similar between with and without transposase. However, at later stages such as 25 days, the cells co-transfected with pT2K-CAGGS-EGFP and pCAGGS-T2TP retained EGFP signals in approximately 15% of total population, whereas almost no cells exhibited EGFP in control where pCAGGS-control was co-transfected with pT2K-CAGGS-EGFP. mediated transgenesis with the tetacycline-induced conditional expression system as described in the accompanying paper (Watanabe et al., 2007-this issue) , so that an introduced exogenous gene can be experimentally controlled to turn on its expression as late as E6, the stage at which the embryo undergoes robust organogenesis. These techniques will open a way where specific roles of genes in late organogenesis can be studied with possible effects of the gene at earlier stages bypassed.
Materials and methods

Vector constructions
pT2K-CAGGS: pT2KXIGΔin (Urasaki et al., 2006) , a modified version of T2KXIG (Kawakami et al., 2004b) was digested with XhoI/BglII to remove the cassette containing the EF1α promoter-EGFP-polyA sequence. This site was blunt-ended, and inserted with a DNA fragment of pCAGGS (Niwa et al., 1991) , prepared by SalI/HindIII, which contains the CAGGS promoter and poly Aadditional sequence of the rabbit beta globin gene. pT2K-CAGGS-EGFP: pT2KXIGΔin was digested with XhoI/BglII, blunt-ended, and inserted with a SalI/HindIII fragment of pCAGGS-EGFP, containing its CAGGS-EGFP-PolyA sequence (Momose et al., 1999) . pCAGGS-T2TP is as described in Kawakami et al., 2004a,b. pT2K-CAGGS-rtTA2 s M2: A cassette for rtTA2 s -M2 (Urlinger et al., 2000) was obtained by EcoRI/BamHI digestion, and inserted into the EcoRI-BglII site of pT2K-CAGGS. pT2K-BI-TRE-EGFP: pT2KXIG was digested with XhoI/BamHI to remove the EF promoter, followed by blunt-ending treatment. This site was inserted with a blunt-ended NotI/AseI fragment derived from pBI-EGFP (CLONTECH), which contains the bidirectional tetracyclineresponsive element (TRE) with two minimal promoters of CMV in both directions, and the polyA-additional sequence of the rabbit beta globin gene.
DF1 transfectants and Southern blot analysis
DF1, an avian cell line purchased from ATCC (Himly et al., 1998) , was maintained in Dulbecco's Modified Eagle's Medium containing 10% fetal calf serum. 5 × 10 5 DF1 cells were plated and subjected to the co-transfection on the following day with 0.5 μg of pT2K-CAGGS-EGFP and the same amount of pCAGGS-T2TP using Lipofectamine 2000 (Invitrogen) as previously described (Tonegawa et al., 1997) . For Southern Blotting, 1/100 of the treated cells at 12 h after the transfection were transferred into a 10-cm dish, and cultured further for 10 days to obtain colonies derived from single cells. Expression of EGFP was confirmed under a fluorescent dissecting microscope (Leica), and colonies exhibiting EGFP were individually selected and obtained. 5 μg of genomic DNAs of the transfectants, prepared by a standard protocol, were digested with EcoRV/XbaI or XbaI, run on a 0.5% agarose gel, transferred to a nylon membrane (Roche), and hybridized with a digoxigenin-labeled probe synthesized from the EcoRV/XbaI fragment of EGFP cDNA. After washing, the hybridized probes were detected with alkaline phosphatase-conjugated sheep anti-digoxigenin (Roche) antibody and a chemiluminescent alkaline phosphatase substrate CDP-Star (Roche). The chemiluminescent images were obtained using Versadoc 5000 (BioRad).
In ovo electroporation and Doxycycline administration into embryos
Electroporation was performed as previously described (Kubo et al., 2005; Sato et al., 2002) . 500 μl of Doxycycline (Dox) solution (0.1 mg/ml in HANKS: 140 mM NaCl, 5.4 mM KCl, 5.6 mM Glucose, 0.34 mM Na 2 HPO 4 , 10 mM HEPES, 1 mM MgCl 2 , 1 mM CaCl 2 pH 7.0) was injected in between the embryo and yolk. Details about Dox administration are also shown in the accompanying paper (Watanabe et al., 2007-this issue) .
Dox-dependent induction of EGFP in DF1 cells
Isolated clonal cells that stably possess transgenes were plated in a 3 cm dish or 24-well dish with the density of 5 × 10 6 /well. On the following day, Dox was added to the culture medium at the concentration of 1 μg/ml. During measurement of EGFP signals by a plate reader (Wallc 1420 ARVOsx), DMEM was temporarily replaced by PBS to avoid auto-fluorescence.
Results
Throughout the studies, we used the transposase-expression plasmid, pCAGGS-T2TP, which contains the transposase cDNA under the control of the strong CAGGS promoter. A transient supply of the CAGGS-controlled transposase appears to be sufficient for the transposition of a transfected/electroporated gene as shown below. Moreover, one assumes that the transient activity of transposase avoids an unnecessary repetition of transposition once a gene has been integrated into the chromosome.
CAGGS-EGFP carried by Tol2 was stably expressed in chicken cells
We first performed a transfection experiment with a Tol2 construct using chicken cell line, DF-1, derived from embryonic fibroblasts. The elongation factor (EF) promoter, although yielding intensive signals of EGFP in mouse cells, is known not to be active enough in chicken cells. We therefore replaced the Xenopus EF1α promoter of pT2KXIGΔin, which contains the EF1α-EGFP cassette between the left and right ends of Tol2 (Urasaki et al., 2006) , by the CAGGS promoter, known to be most suitable for electroporation in chickens, to construct pT2K-CAGGS-EGFP. We transfected this plasmid into DF-1 cells either with the plasmid containing CAGGStransposase (pCAGGS-T2TP), or with the vacant CAGGSplasmid (pCAGGS) as a control (Fig. 1B) . Until 3 days after transfection, a relative ratio of EGFP-positive cells to the total number of cultured cells remained similar between the two sets (at 3 days; pCAGGS-T2TP, 396 ± 28 per 1,000 cells; pCAGGS control, 428 ± 13 per 1,000 cells). In clear contrast, by 6 days after transfection the number of EGFP-positive cells was much greater in the culture with pCAGGS-T2TP (195 ± 22 per 1000 cells) than that of control pCAGGS (92 ± 9 per 1,000 cells). Ultimately, whereas EGFP-positive cells disappeared in the control culture, ∼ 15% of cells remained positive in the culture with pCAGGS-T2TP (149 ±7 per 1000 cells), lasting at least for 25 days (Fig. 1B) .
The CAGGS-EGFP construct was integrated into the chromosome of chicken cells
We next investigated whether the stable expression of EGFP seen above was attributed to an integration of the T2K-CAGGS-EGFP construct into the chromosome of chicken cells. For this Fig. 3 . Persistent expression of EGFP in the Tol2 construct when electroporated into developing chicken embryos. Three kinds of plasmids shown on the top were coelectroporated into developing presomitic mesoderm of chicken embryos. The upper and lower views demonstrate the same specimen at each embryonic stage analyzed, respectively. Until E4, signals for both DsRed2 (not carried by the Tol2 construct) and EGFP (carried by the Tol2 construct) were detected in a similar pattern. However, at E5 onward, EGFP signal persisted until E8, the latest stage analyzed, whereas DsRed2 signal was extinguished by E5. EGFP signals were also observed in muscle precursor cells in developing limb buds, which are also somitic derivatives. purpose, we established four independent cell lines of DF-1 that stably expressed EGFP after transfected with pT2K-CAGGS-EGFP and pCAGGS-T2TP. Genomic DNA was prepared from each of these cell lines, and two sets of specimens for each clone, digested either with EcoRV and XbaI or XbaI only, were subjected to genomic Southern blot analysis (Fig. 2A) . The probe used was an EcoRV-XbaI fragment of the transfected plasmid, which covered the EGFP cDNA. Southern blotting with the EcoRV-XbaI-digested DNA samples yielded a single band with a signal density varying between the four lines, suggesting that the established clones stably retained multiple copy numbers of transgene. In the blot with XbaI digestion, multiple bands with different patterns were detected between the four lines. This indicates that the transgene was integrated into the chromosome and also that multiple copies were integrated in multiple loci, probably randomly, in the same cell ( Fig. 2A) . We also observed that the copy number of integrated transgene was correlated with the signal intensity of EGFP; among these four lines, clone #1 with the lowest copy number exhibited the weakest signal whereas clone #4 with the highest number of copies showed the most intense signal (Fig. 2B) .
The Tol2-EGFP construct was stably expressed after electroporated into PSM in chicken embryos
To determine whether the Tol2-mediated gene transfer would also work in developing chick embryos, we co-electroporated three kinds of plasmids; pT2K-CAGGS-EGFP, pCAGGS-T2TP, and pCAGGS-DsRed2 into the prospective PSM at stage 8. The upper and lower panels of Fig. 3 show the same embryo for each of different time points analyzed. Until E4, signals of both DsRed2 (not cloned in Tol2) and EGFP (cloned in Tol2) were retained (E3, n = 29; E4, n = 10). However, at E5 the intensity of DsRed2 signal descended significantly whereas the EGFP signal was retained at the apparently detectable level (n = 7). The persistent signal of EGFP lasted at least to E8 (E6, n = 12; E7, n = 4; E8, n = 3). As expected, a majority of EGFP signals detected in these embryos were confined to tissues derived from PSM/somites. It is notable that muscles in limbs, which are also somite-derivatives, displayed persistent signals of EGFP (Fig. 3) .
Stable transgenesis in the retinal cells
In addition to the somitic derivatives, we also electroporated the same set of plasmids as above into a developing retina. An electroporation into the optic vesicle at E2 successfully delivered both DeRed2 and EGFP genes into the retina, where signals of these genes were detected in a similar pattern until E3 (n = 25). However, at later stages such as E12, the signal of DsRed2 was completely extinguished whereas EGFP remained positive (Fig. 4, n = 14) . These EGFP-positive cells constituted layers characteristic of the retinal structure.
Combination of the Tol2-mediated gene transfer and tetracycline-dependent conditional expression system
As detailed in the accompanying paper, we have recently developed a technique in chick embryos wherein an electroporated gene can be experimentally induced to be expressed in a tetracycline-dependent fashion (tet-on) (Watanabe et al., 2007-this issue) . We therefore combined, in the present study, the teton system with the Tol2-mediated stable gene transfer as described above.
Before applying these techniques to chicken embryos, we asked whether the combined technique of the Tol2-mediated gene transfer and tet-on system would work in the cultured Fig. 4 . Retained signals of EGFP in developing retinas. The same set of plasmids as shown in Fig. 3 were co-electroporated into an optic cup of E2 embryos. EGFP signals retained at least until E12 with DsRed2 signal undetected, although signals for both EGFP and DeRed2 were obvious by E3. chicken DF-1 cells. For this purpose we used three plasmids (Fig. 5A ): pT2K-CAGGS-rtTA2 S M2, containing the tet-on activator between the left and right ends of Tol2; pT2K-BI-TRE-EGFP containing a cassette of bidirectional transcriptional units under the control of single tet-responsive element (TRE) between the left and right ends of Tol2; pCAGGS-T2TP, which transiently expresses the transposase as described above. The experimental design was as follows: with the activity of transposase, the transposon construct containing either rtTA2 S M2 or TRE-EGFP would be integrated into the chicken chromosome. Since rtTA2 S M2 would ubiquitously be expressed by CAGGS, this transcriptional activator would Fig. 5 . Tet-on induction of cDNA integrated in the chromosome of chicken cells. (A) pT2K-CAGGS-rtTA-M2, pT2K-BI-TRE-EGFP and pCAGGS-T2TP were used for co-transfection into DF1 cells to obtain cell lines that persistently express EGFP. If a cell possesses both CAGGS-rtTA-M2 and TRE-EGFP into the chromosome, the cell would express EGFP in a Dox-dependent manner. (B) Following the transfection, DF1 cells were obtained that stably expressed EGFP for at least 14 days in the presence of Dox. After maintained in culture medium without Dox, these cells were subjected to examination of EGFP signals at different time points after the Dox administration. The signals started to be seen at 3 h, and the intensity ascended afterwards. The same specimen is shown at each time point in bright and dark views.
activate TRE-EGFP provided with doxycycline (an analog of tetracycline, Dox) (Fig. 5A) .
In order to obtain cells that permanently possess the set of the three genes, we transfected DF-1 cells with these plasmids and cultured the cells in the presence of Dox. After culturing for 14 days, we selected three independent clones of EGFP-positive cells. When deprived of Dox, these cells ceased the EGFP expression as expected (data not shown). Using these cell lines, changes in EGFP signals after Dox administration were analyzed. A culture dish was set under a microscope, and was photographed at different time points (0 h, 1 h, 3 h and 6 h) after adding Dox. As shown in Fig. 5B , EGFP signals started to be seen, although weakly, at 3 h onward, and at 6 h the EGFP signal was intense. The progressive increase in EGFP was also quantified by measuring fluorescence intensity (Fig. 5B) . Both the microscopy and quantitative analyses show that the TREdriven EGFP gene appears to turn on its expression around 3 h after Dox was administered. As a control, the same cell lines were treated with PBS, and showed no EGFP-positive cells (Fig. 5B) .
A chromosomally integrated gene by Tol2 was induced to be expressed at later stages by Dox administration
To apply the combined technique of Tol2-mediated gene transfer and the tet-on inducible system to developing embryos, we co-electroporated four different plasmids; the three plasmids as shown above for the cell transfection, along with pCAGGSDsRed2. Fig. 6 shows an example in which electroporated embryos were given with Dox at the end of E5. The upper and lower panels in Fig. 6 describe the same embryo analyzed at each of different time points of development from E3 until E8 (E3, n = 20; E4, n = 25; E5, n = 8; E6, n = 11; E7, n = 3; E8, n = 2). As repeatedly seen, pCAGGS-DsRed2 yielded signals that lasted merely until E5. During this period of time, EGFP signal remained negative because no Dox was present. Fig. 6 . Electroporated genes carried by the Tol2 construct are induced by Dox to be expressed at a late stage of development. Four plasmids shown on the top were used for co-electroporation into developing PSM of chicken embryos. The upper and lower views at each time point of analysis demonstrate the same specimen for DeRed2 and EGFP, respectively. Dox solution was injected at the end of E5 in between the embryo and yolk. Until E5, TRE-driven EGFP signals were not detected although the transgenes were successfully delivered to the somites revealed by DeRed2 (not carried by the Tol2 construct). After E6, EGFP signals started to be seen in tissues derived from somites.
Remarkably, after the Dox administration, EGFP started to be turned on (E6) and the signal persisted at least until E8.
Discussion
We have herein described a novel technique for chicken molecular embryology with which an exogenous gene can be integrated into the host genome mediated by the Tol2 transposition system. The integrated gene(s) appears to be stably expressed if driven by a ubiquitous promoter. We further combined this chromosomal integration technique with the teton inducible system, which we have also established recently for the in ovo electroporation in chickens as described in more detail in the accompanying paper (Watanabe et al., 2007-this issue) . These methods have enabled us to experimentally control the onset of expression of an electroporated gene in a stage-specific manner even at stages later than E5, a stage which could not have been analyzed with the conventional electroporation technique. Developmental stages later than E5 are critical particularly in organogenesis, with numerous tissues interacting to generate complex organ structures and functions. Thus, the techniques proposed in this study are useful and expected to unveil the molecular mechanisms underlying cell-and tissue interactions and cell behaviors such as epithelial-mesenchymal transition and cell migration during late organogenesis.
The Tol2-mediated gene transfer has been used in other model organisms as a powerful tool for genetic screening, particularly for gene-and enhancer trapping in zebrafish. The Tol2 transposon system is also active in frogs and mice (Kawakami, 2005) . Together with our findings described in this study, it is conceivable that a transposition machinery is conserved among different species in vertebrates. It was previously reported that the Drosophila transposon, mariner, underwent transposition on the chicken chromosome (Sherman et al., 1998) . In this case, a plasmid containing the intact mariner transposon was injected into a zygote, and therefore it is thought that the mariner was self-transposed. It would be of interest to compare using chicken cells between Tol2 and another transposition system, Sleeping Beauty (Ivics et al., 1997) , the latter known to be a useful genetic tool in mice (Dupuy et al., 2005) , but less active in zebrafish compared to Tol2 (Kawakami, 2005) .
Using cultured cells in vitro, we have shown that in a relatively high percentage of cells, the electroporated Tol2 constructs can be stably integrated into the chromosomes in the presence of the transposase activity. It remains unknown whether a Tol-2 flanked DNA copies derived from one kind of plasmid are preferably integrated into a single site, or whether copies derived from different kinds of plasmids compose a tandem array before integration. It is also unknown whether all or a part of copies of electroporated DNAs are subjected to the chromosomal integration.
Our experiences in electroporating into PSM cells with a CAGGS-expression vector (Nakaya et al., 2004; Sato et al., 2002) suggest that 20%-50% of PSM cells carry the transgene. In the present study, we found that approximately 40% of the transfected cells permanently retained EGFP signals in vitro.
Thus, in embryos, 8%-20% of the PSM cells are expected to become capable of persistently expressing the electroporated DNA. This proportion of cells carrying a transgene is expected to affect organogenesis/morphogenesis, if the gene has any role at all, at late stages in development. Alternatively, they could at least serve as a good model with which one can study a behavior of individual cells affected cell-autonomously by a transgene as reported for a change in cell shape in individual retinal axons affect by a mutant form of cadherin (Tanabe et al., 2006) .
Last, an increasing number of new techniques have recently emerged, which are useful for molecular embryology in chickens. One such example is that specific enhancer elements of a given gene, which can easily be identified by comparing the genomes of chicken and other vertebrate species, can direct tissue-and cell type-specific expression upon electroporation (Uchikawa et al., 2003 (Uchikawa et al., , 2004 . It is therefore expected that one can further extend this enhancer-directed expression by combining the Tol2-tet-on system, developed in the present study. These techniques will allow a gene manipulation of target cells/tissues in both cell-type specific and stage-specific manners during the relatively late organogenetic stages of development.
